Matches in Nanopublications for { ?s ?p ?o <http://purl.org/np/RA1mFMDNtnDJcNuxY-I2uLbZZwMf6HW2ZiZ1fInDzI2dE#assertion>. }
Showing items 1 to 9 of
9
with 100 items per page.
- association type Statement assertion.
- association label ""Ibandronate sodium is contraindicated in patients with the following conditions: * Abnormalities of the esophagus which delay esophageal emptying such as stricture or achalasia (see Warnings and Precautions [ 5.1 * Inability to stand or sit upright for at least 60 minutes (see Dosage and Administration [2.2], and Warnings and Precautions [ 5.1 * Hypocalcemia (see Warnings and Precautions [ 5.2 * Known hypersensitivity to ibandronate sodium tablets or to any of its excipients. Cases of anaphylaxis have been reported. (see Adverse Reactions [6.2]) * Abnormalities of the esophagus which delay esophageal emptying such as stricture or achalasia ( 4 5.1 * Inability to stand or sit upright for at least 60 minutes ( 4 5.1 * Hypocalcemia ( 4 * Hypersensitivity to ibandronate sodium ( 4"" assertion.
- association object DOID_9164 assertion.
- association predicate treats assertion.
- association subject drugbank:DB00710 assertion.
- association relation MedicalContraindication assertion.
- drugbank:DB00710 category Drug assertion.
- DOID_9164 category Disease assertion.
- association provided_by NeuroDKG assertion.